| Theratechnologies completes Phase III HIV-associated lipodystrophy ... - Pharmaceutical Business Review |
|
|
By Staff Writer The confirmatory Phase III trial is a 400-patient, multi-center, double-blind, randomized, placebo-controlled study conducted in 48 centers ... |